STERIS (NYSE:STE) VP Julia Madsen Sells 2,046 Shares of Stock

STERIS plc (NYSE:STE – Get Free Report) VP Julia Madsen sold 2,046 shares of the business’s stock in a transaction dated Friday, November 13th. The stock was sold at an average price of $260.00, for a total value of $531,960.00. Following the completion of the transaction, the vice president owned 10,211 shares in the company, valued at approximately $2,654,860. This trade represents a 16.69% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

STERIS Stock Down 1.7%

STE traded down $4.49 on Tuesday, reaching $257.42. The company’s stock had a trading volume of 687,501 shares, compared to its average volume of 774,379. The stock has a market cap of $25.00 billion, a price-to-earnings ratio of 30.54 and a beta of 0.86. STERIS plc has a 1 year low of $195.14 and a 1 year high of $269.44. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.05 and a quick ratio of 1.44. The business’s 50 day moving average is $224.02 and its 200 day moving average is $224.61.

STERIS (NYSE:STE – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.68 by $0.26. STERIS had a return on equity of 14.80% and a net margin of 13.41%. The company had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the business earned $2.47 EPS. STERIS’s revenue for the quarter was up 8.8% compared to the same quarter last year. As a group, research analysts forecast that STERIS plc will post 11.46 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Tuesday, November 17th will be issued a $0.69 dividend. The ex-dividend date of this dividend is Tuesday, November 17th. This represents a $2.76 annualized dividend and a yield of 1.1%. STERIS’s dividend payout ratio is currently 32.74%.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. Western Wealth Management LLC acquired a new position in shares of STERIS during the first quarter valued at $25,000. Compass Financial Management LLC bought a new stake in STERIS in the 3rd quarter valued at about $25,000. Elevation Wealth Partners LLC boosted its stake in STERIS by 1,130.0% during the 2nd quarter. Elevation Wealth Partners LLC now owns 123 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 113 shares during the period. Trust Co. of Vermont acquired a new position in STERIS during the 2nd quarter valued at about $41,000. Finally, Community Financial Services Group LLC boosted its stake in STERIS by 50.0% during the 3rd quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 72 shares during the period. 94.69% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on STE shares. Weiss Ratings raised shares of STERIS from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, November 9th. Jefferies Financial Group upgraded STERIS from a “hold” rating to a “buy” rating and boosted their price target for the company from $232.00 to $305.00 in a report on Friday. UBS Group reduced their price target on shares of STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research report on Friday, August 7th. Piper Sandler reaffirmed an “overweight” rating and issued a $275.00 price target (up from $270.00) on shares of STERIS in a report on Friday, August 7th. Finally, Morgan Stanley raised shares of STERIS from an “overweight” rating to a “buy” rating in a research report on Friday. Five equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, STERIS presently has an average rating of “Moderate Buy” and a consensus target price of $283.50.

Get Our Latest Research Report on STERIS

STERIS Company Profile

(Get Free Report)

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.

Featured Stories

Insider Buying and Selling by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.